Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles

Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular pharmacology 1988-04, Vol.11 (4), p.407-412
Hauptverfasser: Hattori, Yoshikazu, Hidaka, Toshinori, Aisaka, Kazuo, Satoh, Fumio, Ishihara, Takafumi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 412
container_issue 4
container_start_page 407
container_title Journal of cardiovascular pharmacology
container_volume 11
creator Hattori, Yoshikazu
Hidaka, Toshinori
Aisaka, Kazuo
Satoh, Fumio
Ishihara, Takafumi
description Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.
doi_str_mv 10.1097/00005344-198804000-00005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78236322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78236322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5315-259f7ad2f1fbed80154b76d3e52ab2e7a692ad6b4758026059e0539c1994856d3</originalsourceid><addsrcrecordid>eNqFks2O0zAUhS0EGkrhEZC8QKwmg3_jZFlKYRCjgoBhGznODQnj2h3bUemj8LYkNHSH8MbyOd-91_IxQpiSK0pK9YqMS3IhMloWBRHjKfsjPUALKjnPBGH8IVoQmpOMCZE_Rk9i_EEIFVLlF-iCCcmV4Av0a9O2YBL2Lf5yu8WU5vISa7yFA_7kE7iEVy71OoTumLpdb_Dq-yheYu9w6gB_6B2k3sSp_rNOkL2BPbhmqnttvbmb9K3G6047BzZi7Rr8bXRDbwarA1571wwm9WO7kdz8TEHHY0zeQnyKHrXaRng270t0-3bzdX2d3Xx89369usmM5FRmTJat0g1raVtDUxAqRa3yhoNkumagdF4y3eS1ULIgLCeyhPHlSkPLUhRyBJfo5anvPvj7AWKqdn00YK124IdYqYLxnDP2X5BKSiknE1icQBN8jAHaah_6nQ7HipJqiq_6G191jm-Wluj5PGOod9CcC-e8Rv_F7OtotG2DdqaPZ0zJUjI13UCcsIO3CUK8s8MBQtWBtqmr_vV5-G-f6LBW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15111302</pqid></control><display><type>article</type><title>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Hattori, Yoshikazu ; Hidaka, Toshinori ; Aisaka, Kazuo ; Satoh, Fumio ; Ishihara, Takafumi</creator><creatorcontrib>Hattori, Yoshikazu ; Hidaka, Toshinori ; Aisaka, Kazuo ; Satoh, Fumio ; Ishihara, Takafumi</creatorcontrib><description>Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-198804000-00005</identifier><identifier>PMID: 2453743</identifier><identifier>CODEN: JCPCDT</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Animals ; Anti-Arrhythmia Agents - pharmacology ; antiarrhythmic agents ; Antiarythmic agents ; Benzeneacetamides ; Biological and medical sciences ; Cardiac Complexes, Premature - physiopathology ; cardiac muscle ; Cardiovascular system ; Disopyramide - pharmacology ; Guinea Pigs ; Heart Conduction System - drug effects ; Heart Ventricles - drug effects ; In Vitro Techniques ; Ion Channels - drug effects ; Lidocaine - analogs &amp; derivatives ; Lidocaine - pharmacology ; Male ; Medical sciences ; Mexiletine - pharmacology ; Papillary Muscles - drug effects ; Pharmacology. Drug treatments ; Piperidines - pharmacology ; sodium ; Sodium - metabolism</subject><ispartof>Journal of cardiovascular pharmacology, 1988-04, Vol.11 (4), p.407-412</ispartof><rights>Lippincott-Raven Publishers.</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5315-259f7ad2f1fbed80154b76d3e52ab2e7a692ad6b4758026059e0539c1994856d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00005344-198804000-00005$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00005344-198804000-00005$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7595272$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2453743$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hattori, Yoshikazu</creatorcontrib><creatorcontrib>Hidaka, Toshinori</creatorcontrib><creatorcontrib>Aisaka, Kazuo</creatorcontrib><creatorcontrib>Satoh, Fumio</creatorcontrib><creatorcontrib>Ishihara, Takafumi</creatorcontrib><title>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.</description><subject>Animals</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>antiarrhythmic agents</subject><subject>Antiarythmic agents</subject><subject>Benzeneacetamides</subject><subject>Biological and medical sciences</subject><subject>Cardiac Complexes, Premature - physiopathology</subject><subject>cardiac muscle</subject><subject>Cardiovascular system</subject><subject>Disopyramide - pharmacology</subject><subject>Guinea Pigs</subject><subject>Heart Conduction System - drug effects</subject><subject>Heart Ventricles - drug effects</subject><subject>In Vitro Techniques</subject><subject>Ion Channels - drug effects</subject><subject>Lidocaine - analogs &amp; derivatives</subject><subject>Lidocaine - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mexiletine - pharmacology</subject><subject>Papillary Muscles - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - pharmacology</subject><subject>sodium</subject><subject>Sodium - metabolism</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks2O0zAUhS0EGkrhEZC8QKwmg3_jZFlKYRCjgoBhGznODQnj2h3bUemj8LYkNHSH8MbyOd-91_IxQpiSK0pK9YqMS3IhMloWBRHjKfsjPUALKjnPBGH8IVoQmpOMCZE_Rk9i_EEIFVLlF-iCCcmV4Av0a9O2YBL2Lf5yu8WU5vISa7yFA_7kE7iEVy71OoTumLpdb_Dq-yheYu9w6gB_6B2k3sSp_rNOkL2BPbhmqnttvbmb9K3G6047BzZi7Rr8bXRDbwarA1571wwm9WO7kdz8TEHHY0zeQnyKHrXaRng270t0-3bzdX2d3Xx89369usmM5FRmTJat0g1raVtDUxAqRa3yhoNkumagdF4y3eS1ULIgLCeyhPHlSkPLUhRyBJfo5anvPvj7AWKqdn00YK124IdYqYLxnDP2X5BKSiknE1icQBN8jAHaah_6nQ7HipJqiq_6G191jm-Wluj5PGOod9CcC-e8Rv_F7OtotG2DdqaPZ0zJUjI13UCcsIO3CUK8s8MBQtWBtqmr_vV5-G-f6LBW</recordid><startdate>198804</startdate><enddate>198804</enddate><creator>Hattori, Yoshikazu</creator><creator>Hidaka, Toshinori</creator><creator>Aisaka, Kazuo</creator><creator>Satoh, Fumio</creator><creator>Ishihara, Takafumi</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198804</creationdate><title>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</title><author>Hattori, Yoshikazu ; Hidaka, Toshinori ; Aisaka, Kazuo ; Satoh, Fumio ; Ishihara, Takafumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5315-259f7ad2f1fbed80154b76d3e52ab2e7a692ad6b4758026059e0539c1994856d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Animals</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>antiarrhythmic agents</topic><topic>Antiarythmic agents</topic><topic>Benzeneacetamides</topic><topic>Biological and medical sciences</topic><topic>Cardiac Complexes, Premature - physiopathology</topic><topic>cardiac muscle</topic><topic>Cardiovascular system</topic><topic>Disopyramide - pharmacology</topic><topic>Guinea Pigs</topic><topic>Heart Conduction System - drug effects</topic><topic>Heart Ventricles - drug effects</topic><topic>In Vitro Techniques</topic><topic>Ion Channels - drug effects</topic><topic>Lidocaine - analogs &amp; derivatives</topic><topic>Lidocaine - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mexiletine - pharmacology</topic><topic>Papillary Muscles - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - pharmacology</topic><topic>sodium</topic><topic>Sodium - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hattori, Yoshikazu</creatorcontrib><creatorcontrib>Hidaka, Toshinori</creatorcontrib><creatorcontrib>Aisaka, Kazuo</creatorcontrib><creatorcontrib>Satoh, Fumio</creatorcontrib><creatorcontrib>Ishihara, Takafumi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hattori, Yoshikazu</au><au>Hidaka, Toshinori</au><au>Aisaka, Kazuo</au><au>Satoh, Fumio</au><au>Ishihara, Takafumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1988-04</date><risdate>1988</risdate><volume>11</volume><issue>4</issue><spage>407</spage><epage>412</epage><pages>407-412</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><coden>JCPCDT</coden><abstract>Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>2453743</pmid><doi>10.1097/00005344-198804000-00005</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-2446
ispartof Journal of cardiovascular pharmacology, 1988-04, Vol.11 (4), p.407-412
issn 0160-2446
1533-4023
language eng
recordid cdi_proquest_miscellaneous_78236322
source MEDLINE; Journals@Ovid LWW Legacy Archive; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Animals
Anti-Arrhythmia Agents - pharmacology
antiarrhythmic agents
Antiarythmic agents
Benzeneacetamides
Biological and medical sciences
Cardiac Complexes, Premature - physiopathology
cardiac muscle
Cardiovascular system
Disopyramide - pharmacology
Guinea Pigs
Heart Conduction System - drug effects
Heart Ventricles - drug effects
In Vitro Techniques
Ion Channels - drug effects
Lidocaine - analogs & derivatives
Lidocaine - pharmacology
Male
Medical sciences
Mexiletine - pharmacology
Papillary Muscles - drug effects
Pharmacology. Drug treatments
Piperidines - pharmacology
sodium
Sodium - metabolism
title Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A14%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20SUN%201165,%20a%20New%20Potent%20Antiarrhythmic%20Agent,%20on%20the%20Kinetics%20of%20Rate-Dependent%20Block%20of%20Na%20Channels%20and%20Ventricular%20Conduction%20of%20Extrasystoles&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Hattori,%20Yoshikazu&rft.date=1988-04&rft.volume=11&rft.issue=4&rft.spage=407&rft.epage=412&rft.pages=407-412&rft.issn=0160-2446&rft.eissn=1533-4023&rft.coden=JCPCDT&rft_id=info:doi/10.1097/00005344-198804000-00005&rft_dat=%3Cproquest_cross%3E78236322%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15111302&rft_id=info:pmid/2453743&rfr_iscdi=true